Use the keywords feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
JOURNAL ARTICLE
Abel A Pavía-López, José A Magaña-Serrano, José A Cigarroa-López, Adolfo Chávez-Mendoza, José L Mayorga-Butrón, Diego Araiza-Garaygordobil, Juan B Ivey-Miranda, Gustavo F Méndez-Machado, Héctor González-Godínez, Luisa F Aguilera-Mora, Antonio Jordán-Ríos, Luis Olmos-Domínguez, Marcos J Olalde-Román, Emma M Miranda-Malpica, Zuilma Vázquez-Ortiz, Jorge Rayo-Chávez, Alexandra A Mendoza, Manlio F Márquez-Murillo, Sergio A Chávez-Leal, Amada Álvarez-San Gabriel, Marissa A Silva-García, Alex D Pacheco-Bouthiller, Jorge A Aldrete-Velazco, Carlos A Guizar-Sánchez, Efraín Gaxiola-López, Arturo Guerra-López, Lourdes Figueiras-Graillet, Gustavo Sánchez-Miranda, Genaro H Mendoza-Zavala, Moisés Aceves-García, Adolfo Chávez-Negrete, Marisol Arroyo-Hernández, Bertha B Montaño-Velázquez, Luis F Romero-Moreno, María M Baquero-Hoyos, Liliana Velasco-Hidalgo, Ana L Rodríguez-Lozano, Nancy E Aguilar-Gómez, Mario Rodríguez-Vega, Jorge E Cossío-Aranda
Chronic heart failure continues to be one of the main causes of impairment in the functioning and quality of life of people who suffer from it, as well as one of the main causes of mortality in our country and around the world. Mexico has a high prevalence of risk factors for developing heart failure, such as high blood pressure, diabetes, and obesity, which makes it essential to have an evidence-based document that provides recommendations to health professionals involved in the diagnosis and treatment of these patients...
2024: Archivos de Cardiología de México
#2
B Güvendi Sengor, C Yilmaz, M F Keten, R Zehir
Hypertension is one of the most powerful and modifiable risk factors for the development, progression and even decompensation of heart failure. Uncontrolled hypertension increases to frequency of heart failure hospitalizations by increase sympathetic tone. Catheter-based renal denervation has been shown to reduce blood pressure in the treatment of multidrug-resistant hypertension. We report the improvement in clinical status after renal denervation in a 47-year-old male patient with a history of hypertension, chronic ischemic heart failure, and recurrent hospitalizations for acute hypertensive pulmonary edema despite optimal medical therapy...
April 18, 2024: Hipertensión y Riesgo Vascular
#3
JOURNAL ARTICLE
María Alejandra Restrepo-Córdoba, Przemyslaw Chmielewski, Grażyna Truszkowska, María Luisa Peña-Peña, Miloš Kubánek, Alice Krebsová, Luis R Lopes, Álvaro García-Ropero, Marco Merlo, Alessia Paldino, Stacey Peters, Ruxandra Jurcut, Roberto Barriales-Villa, Esther Zorio, Mark Hazebroek, Jens Mogensen, Pablo García-Pavía
INTRODUCTION AND OBJECTIVES: Limited information is available on the safety of pregnancy in patients with genetic dilated cardiomyopathy (DCM) and in carriers of DCM-causing genetic variants without the DCM phenotype. We assessed cardiac, obstetric, and fetal or neonatal outcomes in this group of patients. METHODS: We studied 48 women carrying pathogenic or likely pathogenic DCM-associated variants (30 with DCM and 18 without DCM) who had 83 pregnancies. Adverse cardiac events were defined as heart failure (HF), sustained ventricular tachycardia, ventricular assist device implantation, heart transplant, and/or maternal cardiac death during pregnancy, or labor and delivery, and up to the sixth postpartum month...
April 17, 2024: Revista Española de Cardiología
#4
JOURNAL ARTICLE
Ulises Rojel-Martínez, Carlos De-la-Fuente-Macip, Arturo Enríquez-Silverio, Karla I Bozada-Nolasco, Pablo A Reátiga-Vega, Flor M Marquez Marquez-Maldonado
OBJECTIVE: To describe the initial experience of cardiac contractility modulation (CCM) implantation in Latin America. METHOD: We present the first two cases in Latin America of patients with heart failure with reduced left ventricular ejection fraction (LVEF) not candidates for cardiac resynchronization therapy in whom a CCM device was implanted. Results. RESULTS: In both patients we described improvement of the 6-minute walk test, functional class according to the NYHA and LVEF...
April 17, 2024: Archivos de Cardiología de México
#5
JOURNAL ARTICLE
S Yun, J Casado, J Pérez-Silvestre, P Salamanca, P Llàcer, R Quirós, R Ruiz-Hueso, M Méndez, L Manzano, F Formiga
In recent years, the interest in cardiac amyloidosis has grown exponentially. However, there is a need to improve our understanding of amyloidosis in order to optimise early detection systems. Therefore, it is crucial to incorporate solutions to improve the suspicion, diagnosis and follow-up of cardiac amyloidosis. In this sense, we designed a tool following the different phases to reach the diagnosis of cardiac amyloidosis, as well as an optimal follow-up: a) clinical suspicion, where the importance of the "red flags" to suspect it and activate the diagnostic process is highlighted; 2) diagnosis, where the diagnostic algorithm is mainly outlined; and 3) follow-up of confirmed patients...
April 11, 2024: Revista Clínica Espanõla
#6
JOURNAL ARTICLE
Nicolas L'Hermitte, Thibaut Markarian, Laura Grau-Mercier, Fabien Coisy, Laurent Muller, Laysa Saadi, Pierre-Géraud Claret, Hugo Krebs, Xavier Bobbia
OBJECTIVES: To study the diagnostic performance of an ultrasound-based algorithm that includes the deceleration time (DT) of early mitral filling to establish a diagnosis of acute heart failure (AHF) in patients who come to an emergency department because of dyspnea. MATERIAL AND METHODS: Prospective analysis in a convenience sample of patients who came to a hospital emergency department with acute dyspnea. The algorithm included ultrasound findings and 4 echocardiographic findings as follows: mitral annular plane systolic excursion, Doppler mitral flow velocity, tissue Doppler imaging measure of the lateral annulus, and the DT of early mitral filling...
April 2024: Emergencias: Revista de la Sociedad Española de Medicina de Emergencias
#7
REVIEW
Aleix Cases, Secundino Cigarrán, José Luis Górriz, Julio Nuñez
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) have demonstrated cardiovascular and renal benefits in patients with type 2 diabetes mellitus, heart failure, or chronic kidney disease. Since the first studies with these drugs, an initial increase in hemoglobin/hematocrit levels was observed, which was attributed to an increase in hemoconcentration associated with its diuretic effect, although it was early appearent that these drugs increased erythropoietin levels and erythropoiesis, and improved iron metabolism...
April 10, 2024: Nefrología
#8
JOURNAL ARTICLE
Manuel Martínez-Sellés
No abstract text is available yet for this article.
April 2024: Emergencias: Revista de la Sociedad Española de Medicina de Emergencias
#9
EDITORIAL
Effie Polyzogopoulou, John Parissis, Vasiliki Bistola
No abstract text is available yet for this article.
April 2024: Emergencias: Revista de la Sociedad Española de Medicina de Emergencias
#10
JOURNAL ARTICLE
P de Peralta García, M Bolzoni, M Yebra Yebra, M Asenjo Martín, M Arrondo Turrado, M A Domínguez Sepúlveda, J A Rueda Camino, R Barba Martín
BACKGROUND: some studies suggest that hypochloremia is a risk factor in the prognosis of heart failure (HF) in patients with recent decompensation. MATERIALS AND METHODS: retrospective cohort study of patients discharged due to HF decompensation who began follow-up in a specialized clinic. Two groups are defined: patients with hypochloremia (chloride < 98 mmol/L) and normochloremic patients (chloride > 98 mmol/L) in the initial assessment within the first month after discharge...
April 6, 2024: Revista Clínica Espanõla
#11
JOURNAL ARTICLE
Carla Barbosa, Camila Dias, Elisabete Martins, André Cabrita
INTRODUCTION AND OBJECTIVES: Cardiovascular diseases (CVD) and cancer are some of the most recognized causes of mortality and morbidity worldwide. Cancer is the second leading cause of death in heart failure (HF) populations. Recent studies have hypothesized that HF might promote the development and progression of cancer. We aim to analyze and discuss the most recent evidence on the relationship between HF and cancer development. METHODS: From inception to November 2022, we searched PubMed, Web of Science and ClinicalTrials...
April 5, 2024: Portuguese Journal of Cardiology: An Official Journal of the Portuguese Society of Cardiology
#12
JOURNAL ARTICLE
Héctor Rodríguez-Ramallo, Nerea Báez-Gutiérrez, Didiana Jaramillo-Ruiz, Gabriel Sanfélix-Gimeno, Román Villegas-Portero, José Luis Jiménez-Murillo, Carlos Hernández-Quiles, Bernardo Santos-Ramos
UNLABELLED: Heart failure is a prevalent syndrome with high mortality rates, representing a significant economic burden in terms of healthcare. The lack of systematic information about the treatment and adherence of patients with heart failure limits the understanding of these aspects and potentially the improvement of clinical outcomes. OBJECTIVE: To describe the clinical characteristics, therapeutic management, adherence, persistence and clinical results, as well as the association between these variables, in a cohort of patients with heart failure in Andalusia...
April 5, 2024: Farmacia Hospitalaria
#13
EDITORIAL
Juan Torres Macho, Mercedes Duffot Falcó
No abstract text is available yet for this article.
April 4, 2024: Medicina Clínica
#14
JOURNAL ARTICLE
J Cuevas Pérez, D Moro Quesada, V Alonso Fernández, M Á Prieto-Díaz, B Prieto García, P Herrero Puente, V Chiminazzo, R Ludeña Martín-Tesorero, J M de la Hera Galarza
INTRODUCTION: There are few data about the optimal use of natriuretic peptides (NP) in the Primary Care (PC) setting. The aim to assess how, through a common coordinated PC-hospital care pathway, the use of NPs in patients with suspected heart failure (HF) is improved. MATERIAL AND METHODS: Analytical, experimental, prospective, non-randomized study. An intervention group composed of 22 PC physicians from 2 health centers is provided with face-to-face training and a consensual protocol is attached with a cut-off point of NT-proBNP> 300 pg/mL as pathological...
March 29, 2024: Semergen
#15
JOURNAL ARTICLE
Ulises Gómez-Álvarez, Juan C de la Fuente-Mancera, Neftali E Antonio-Villa, Amada Álvarez-Sangabriel, Carlos A Guizar-Sánchez, Fernando Tenorio-Bautista
BACKGROUND: In Mexico, the epidemiology of heart failure is still not well understood. However, it is known that the primary cause of hospital admissions in patients with heart failure is pulmonary and systemic congestion. OBJECTIVE: To estimate congestion status and assess cardiac function using portable ultrasound in patients with heart failure. METHOD: A cross-sectional observational study was conducted. Patients who attended the Heart Failure Clinic at the Ignacio Chávez National Cardiology Institute in Mexico City between May and August 2022 were selected...
2024: Archivos de Cardiología de México
#16
JOURNAL ARTICLE
Lucrecia M Burgos, Franco Ballari, Maximiliano Massa, María L Talavera, Mariano Benzadón, Mirta Díez
BACKGROUND: Virtual consultations have increased exponentially, but a limitation is the inability to assess vital signs (VS). This is particularly useful in patients with heart failure (HF) for titrating prognosis-modifying medication. This issue could potentially be addressed by a tool capable of measuring blood pressure (BP) and heart rate (HR) accurately, remotely, and conveniently. Mobile phones equipped with transdermal optical imaging technology could meet these requirements. OBJECTIVE: To evaluate the accuracy of a transdermal optical imaging-based app for estimating VS compared to clinical assessment in patients with HF...
2024: Archivos de Cardiología de México
#17
JOURNAL ARTICLE
Juan C Plata-Corona, Fabio Solis-Jiménez, Maximiliano Flores-Flamand, Carlos A Dattoli-García, Ángel A Priego-Ranero, Jorge D Sierra-Lara, Carlos R Sierra-Fernández
BACKGROUND: Cardiac resynchronization therapy (CRT) has been established as an effective therapy for heart failure with reduced ejection fraction. Randomized clinical trials have shown its impact on mortality and HF hospitalizations, as well as improvement of symptoms and quality of life. OBJECTIVES: Finding clinical, electrocardiographic, and echocardiographic variables that may predict the response to cardiac resynchronization therapy (CRT). METHODS: We performed a single-center, observational, analytic, and retrospective study that included 102 patients with heart failure (HF) diagnosis who underwent CRT according to guideline-directed therapy from January 2010 to April 2020 in a third-level center...
2024: Archivos de Cardiología de México
#18
JOURNAL ARTICLE
Santiago Decotto, Giuliana Corna, Eugenia Villanueva, Diego Pérez-de Arenaza, Ignacio Seropian, Mariano Falconi, Pablo Oberti, Ma Adela Aguirre, Ma Lourdes Posadas-Martínez, Marcelina Carretero, Carla R Agatiello, Rodolfo Pizarro
BACKGROUND: Aortic stenosis (AS) is currently the most common valvular disease, with an estimated prevalence of over 4% in octogenarians. OBJECTIVE: To describe the prevalence of moderate-severe aortic stenosis (AS) in patients with wild type transthyretin amyloidosis (ATTRwt). Also, describe the clinical features, echocardiographic characteristics and clinical evolution. METHOD: Retrospective cohort of patients with diagnosis of ATTRwt, belonging to Hospital Italiano de Buenos Aires Institutional Amyloidosis Registry, from 30/11/2007 to 31/05/2021...
2024: Archivos de Cardiología de México
#19
JOURNAL ARTICLE
Sergio A Gómez-Ochoa, Angie Yarlady Serrano-García, Alexandra Hurtado-Ortiz, Andrea Aceros, Lyda Z Rojas, Luis E Echeverría
INTRODUCTION AND OBJECTIVES: Although multiple studies suggest that chronic Chagas cardiomyopathy (CCC) has higher mortality than other cardiomyopathies, the absence of meta-analyses supporting this perspective limits the possibility of generating robust conclusions. The aim of this study was to systematically evaluate the current evidence on mortality risk in CCC compared with that of other cardiomyopathies. METHODS: PubMed/Medline and EMBASE were searched for studies comparing mortality risk between patients with CCC and those with other cardiomyopathies, including in the latter nonischemic cardiomyopathy (NICM), ischemic cardiomyopathy, and non-Chagas cardiomyopathy (nonCC)...
March 12, 2024: Revista Española de Cardiología
#20
JOURNAL ARTICLE
Luis Zapata, Rocío Gómez-López, Celina Llanos-Jorge, Jorge Duerto, Luis Martin-Villen
Cardiogenic shock (CS) is a heterogeneous syndrome with high mortality and a growing incidence. It is characterized by an imbalance between the tissue oxygen demands and the capacity of the cardiovascular system to meet these demands, due to acute cardiac dysfunction. Historically, acute coronary syndromes have been the primary cause of CS. However, non-ischemic cases have seen a rise in incidence. The pathophysiology involves ischemic damage of the myocardium and a sympathetic, renin-angiotensin-aldosterone system and inflammatory response, perpetuating the situation of tissue hypoperfusion and ultimately leading to multiorgan dysfunction...
March 7, 2024: Medicina intensiva
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
